Study on Abacavir drug hypersensitivity among HIV infected adult patients
Not Applicable
Completed
- Conditions
- Health Condition 1: B20- Human immunodeficiency virus [HIV]disease
- Registration Number
- CTRI/2019/07/020202
- Lead Sponsor
- Manipal McGill Center for Infectious Diseases
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients with HIV infection of both the gender and above 18 years of age presenting to the HIV clinic, Kasturba Hospital Manipal will be included in the study.
Exclusion Criteria
HIV infected children below 18 years of age will be excluded from the study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method This study will help in obtaining the frequency of HIV infected patients carrying HLA-B57:01 allele in our setting. This would help in predicting those individuals who are susceptible to develop abacavir HSR.Timepoint: July 2019 - June 2020
- Secondary Outcome Measures
Name Time Method To document the usage of abacavir based anti-retroviral treatment regimens and their adverse effect profile in the HIV clinic.Timepoint: July 2019 - June 2020